Document Dates

May 18, 2026 (Financial Results) & August 13, 2026 (AGM Notice)

Financial Performance

Diamines and Chemicals reported severely negative financial results for FY 2025-26, with consolidated net loss of ₹127.83 crore (₹1,278.31 lakh) compared to a profit of ₹27.31 crore (₹273.06 lakh) in FY25. This represents a dramatic reversal driven by a 46.2% decline in revenue from operations to ₹384.79 crore (₹3,847.92 lakh) from ₹714.72 crore (₹7,147.15 lakh) in the previous year.

Key Financial Metrics

Consolidated P&L (₹ in Lakhs):

  • Revenue from Operations: 3,847.92 (FY25: 7,147.15)
  • Total Expenses: 5,637.51 (FY25: 6,986.78)
  • Loss Before Tax: (1,395.70) (FY25: Profit 477.88)
  • Net Loss: (1,278.31) (FY25: Net Profit 273.06)
  • Basic EPS: (₹13.06) (FY25: ₹2.79)

Balance Sheet (₹ in Lakhs):

  • Total Assets: 17,444.18 (FY25: 17,809.01)
  • Property, Plant & Equipment: 6,510.70
  • Capital Work-in-Progress: 1,941.36 (significant increase from 226.07)
  • Cash & Cash Equivalents: 16.95 (FY25: 2,192.38)
  • Trade Receivables: 546.71 (FY25: 1,384.34)

Segment Performance

Both business segments underperformed:

  • Specialty Chemicals: Revenue declined to ₹384.79 crore with segment loss of ₹100.67 crore
  • Trading in Fruits & Vegetables: Revenue dropped to zero with segment loss of ₹35.81 crore

Significant Provisions and Write-downs

The company recognized substantial provisions including:

  • Loss allowance on trade receivables: ₹361.43 lakh
  • Inventory written down to net realizable value: ₹384.54 lakh
  • These provisions significantly contributed to the overall negative results

Capital Expenditure and Expansion

Despite the financial challenges, the company increased capital expenditure significantly to ₹213.51 crore from ₹40.13 crore in FY25, primarily for ongoing projects in the specialty chemicals segment, indicating continued investment in future growth.

50th Annual General Meeting

The company will convene its 50th AGM on September 16, 2026, to:

  • Approve audited standalone and consolidated financial statements for FY26
  • Reappoint Mr. Tanmay Godiawala as Executive Director for 3 years with monthly CTC of ₹4,03,200
  • Reappoint Mr. Rajendra Chhabra as Non-Executive Professional Director
  • Ratify remuneration of cost auditors and approve commission to non-executive directors

Corporate Governance and Regulatory Compliance

The Board comprises 6 directors (2 Executive, 4 Non-Executive including 3 Independent). The company received a minor penalty of ₹10,000 for delay in providing information of change in Directors but maintains overall regulatory compliance with SEBI requirements.

Subsidiaries and Associates

  • DACL Fine Chem Limited (Wholly Owned Subsidiary): Investment ₹1,345.24 lakhs, outstanding loan ₹673.94 lakhs
  • KLJ Organic Diamines Limited (Associate/Joint Venture): Investment ₹175.00 lakhs, outstanding loan ₹284.41 lakhs

Dividend Declaration

No dividend declared for FY 2025-26 due to losses, compared to 10% dividend paid in FY 2024-25.

Voting and Shareholder Information

  • Remote e-voting period: September 12-15, 2026
  • Cut-off date for voting eligibility: September 9, 2026
  • Book Closure: September 10-16, 2026
  • Scrutinizer: Mr. Sandip Sheth of M/s. Sandip Sheth & Associates

The company faces significant challenges from the substantial FY26 losses but continues to invest in expansion projects while maintaining corporate governance standards through proper AGM procedures and regulatory compliance.